Inhibition of N-linked glycosylation using tunicamycin causes cell death in malignant cells: Role of down-regulation of the insulin-like growth factor 1 receptor in induction of apoptosis

Cancer Research

Volumn 57, Issue 3, 1997, Pages 543-548

  Dricu, Anica ^a   Carlberg, Magdalena ^a   Wang, Min ^a   Larsson, Olle ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; RECEPTOR PROTEIN; SOMATOMEDIN C RECEPTOR; TUNICAMYCIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL DEATH; CELL SURFACE; CELL TRANSFORMATION; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; GLYCOSYLATION; HEP 2 CELL; HEPATOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SIMIAN VIRUS 40;

APOPTOSIS; DOWN-REGULATION; GLYCOSYLATION; HUMANS; NEOPLASMS; RECEPTOR, IGF TYPE 1; TUMOR CELLS, CULTURED; TUNICAMYCIN;

EID: 0031043731     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Larson, O., Carlberg, M., and Zetterberg, A. Selective killing induced by an inhibitor of N-linked glycosylation. J. Cell Sci., 106: 299-307, 1993.
2. Heifetz, A., Keenan, R. W., and Elbein, A. D. Mechanism of action of tunicamycin on the UDP-GlcNAc: dolichyl-phosphate GlcNAc-1-phosphate transferas. Biochemistry, 18: 2186-2192, 1979.
3. Carlberg, M., Dricu, A., Blegen, H., Kass, G. E. N., Orrenius, S., and Larsson, O. Short exposures to tunicamycin induce apoptosis in SV40-transformed but not in normal human fibroblasts. Carcinogenesis (Lond.), 17: 2589-2596, 1996.
4. Evan, G., Wyllie, A. H., Gilberts, C. S., Littlewood, T. D., Land, H., Brooks, M., Peen, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
5. Carlberg, M., Dricu, A., Blegen, H., Wang, M. Hjertman, M., Zickert, P., Höög, A., and Larsson, O. Mevulonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. J. Biol. Chem., 271: 17453-17462, 1996.
6. Sorensen, C. M., Barry, M. A., and Eastman, A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J. Natl. Cancer Inst., 82: 749-754, 1990.
7. Gammeltoft, S. Peptide hormone receptors. In: J. C. Hutton and K. Siddle (eds.), Peptide Hormone Action: A Practical Approach, pp. 1-41. Oxford, United Kingdom: Oxford University Press, 1991.
8. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor 1 receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
9. Thastrup, O., Dawson, A. P., Scharff, O., Foder, B., Cullen, P. J., Drobak, B. K., Bjerrum, P. J., Christensen, S. B., and Hanley, M. R. Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents Actions, 27: 17-23, 1989.
10. Yasugi, E., Yokoyama, Y., Seyama, Y., Kano, K., Hayashi, Y., and Oshima, M. Dolichyl phosphate is a potent inducer of apoptosis in rat glioma C6 cells. Biochem. Biophys. Res. Commun., 276: 848-853, 1995.
11. Ullrich, A., Gray, A., Tam, A. W., Yang-Feneg, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., Chen, E., Jacobs, S., Francke, U., Ramachandran, J., and Fujita-Yamaguchi, Y. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J., 5: 2503-2512, 1986.
12. Baserga, R. The insulin-like growth factor 1 receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
13. cdc2. Cancer Res., 54: 5531-5534, 1994.
14. Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R., and Rubin, R. Rat glioblastoma cells expressing antisense RNA to insulin-like growth factor-1 (IGF-1) receptor are nontumorgenic and induce regression of wild-type tumors. Cancer Res., 54: 2218-2222, 1994.
15. Resnicoff, M., Coppola, D., Sell, C., Rubin, R., Ferrone, S., and Baserga, R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res., 54: 4848-4850, 1994.
16. Shapiro, D. N., Jones, B. G., Shapiro, L. H., Dias, P., and Houghton, P. J. Antisense-mediated reduction in insulin-like growth factor 1 receptor expression suppresses the malignant phenotype of human alveolar rhabdomyosarcoma. J. Clin. Invest., 94: 1235-1242, 1994.
17. Prager, D., Li, H. L., Asa, S., and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor mutant. Proc. Natl. Acad. Sci. USA, 97:2181-2185, 1994.
18. Harrington, E. A., Bennet, M. R., Fanidi, A., and Evan, G. I. c-myc- induced apoptosis in fibre-blasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
19. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
20. Chang, J. Y., and Korolev, V. Specific toxicity in induction of programmed cell death of sympathetic neurons. Exp. Neurol., 137: 201-211, 1996.
21. 2+ fluxes. Oncogene, 11: 2165-2174, 1995.
22. 2+ fluxes. Proc. Natl. Acad. Sci. USA, 97: 6569-6573, 1994.